Indications
A-Tetra is a broad-spectrum antibiotic. It is highly effective in the treatment of infections caused by Borrelia recurrentis (relapsing fever), Calymmatobacterium granulomatis (granuloma inguinale), Chlamydia species (psittacosis, lymphogranuloma venereum, trachoma, inclusion conjunctivitis), Francisella tularensis (tularaemia), Haemophilus ducreyi (chancroid), Leptospira (meningitis, jaundice), Mycoplasma pneumoniae (non-gonococcal urethritis), Pseudomonas mallei (glanders and melioidosis), Rickettsiae (typhus fever, Q-fever, Rocky Mountain spotted fever), and Vibrio species (cholera). It is also highly effective alone or in combination with streptomycin in the treatment of infections due to Brucella species (brucellosis), plague, and severe acne vulgaris. In acute intestinal amoebiasis, A-Tetra is a useful adjunct to amoebicides. A-Tetra is indicated in pneumonia, tetanus, gas gangrene, dysentery, and as second or third line therapy in gonorrhoea and syphilis. It is used as an adjunct therapy with bismuth subcitrate and metronidazole for eradicating H. pylori in the treatment of gastric and duodenal ulcer.
Pharmacology
Tetracycline is a broad-spectrum antibiotic which is bacteriostatic for many bacteria, rickettsiae, chlamydia, mycoplasma, and brucella. It exerts its antimicrobial effect by inhibiting protein synthesis. After a single oral dose of Tetracycline, peak plasma concentration is attained in 2 to 4 hours. The drug's half-life is in the range of 6 to 9 hours. Because of its enterohepatic circulation, Tetracycline may be present in the blood for a long time after cessation of therapy.
Dosage & Administration
Tetracycline is administered orally, typically taken with water, adhering to schedules provided by a healthcare professional. Administration timing relative to meals is evaluated based on individual clinical guidance.
Administration Guidelines:
Therapy duration is generally continued for a period determined by a physician after clinical symptoms subside. It should be used with caution in the treatment of elderly patients where accumulation is a possibility.
Interaction
A-Tetra in combination with methoxyflurane may result in nephrotoxicity. Antacids containing calcium, aluminium, or magnesium impair the absorption of tetracycline and result in decreased serum level. A-Tetra inhibits the antimicrobial activity of penicillin when used concomitantly.
Contraindications
A history of hypersensitivity to tetracycline, in cases of overt renal insufficiency, children under 12 years of age, and pregnant or lactating women.
Side Effects
Gastrointestinal disturbances e.g. glossitis, stomatitis, vaginitis, or staphylococcal enterocolitis. Photosensitivity and dermatological reactions are rare. Bulging fontanelles in infants and benign intracranial hypertension in adults have been reported. Treatment should be ceased if intracranial pressure rises. Hypersensitivity reactions include purpura, pericarditis, angioneurotic oedema, anaphylaxis, anaphylactoid purpura, and exacerbation of systemic lupus erythematosus may occur. Haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia have been reported.
Pregnancy & Lactation
Tetracycline crosses the placenta, is found in foetal tissues, and has embryotoxic effects. Therefore, tetracycline should not be used in pregnancy unless considered essential under medical supervision. Tetracycline has been found in human milk. Permanent tooth discoloration may occur in the developing infant and enamel hypoplasia has been reported.
Precautions & Warnings
Absorption of tetracycline is impaired by the concomitant administration of milk and by calcium, magnesium, iron, and particularly aluminium salts commonly used as antacids. A-Tetra depresses plasma prothrombin activity; therefore, reduced dosage of concurrent anticoagulants may be required under medical supervision. Lower doses are indicated in cases of renal impairment to avoid excessive systemic accumulation, and if therapy is prolonged, serum level determinations are advisable. The concomitant use of oral tetracycline may reduce the efficacy of oral contraceptives and penicillins; an increased incidence of breakthrough bleeding may also be experienced. It should only be used with great caution in conjunction with other potentially hepatotoxic drugs.
Therapeutic Class
Tetracycline group of drugs
Storage Conditions
Store in a cool and dry place. Protect from light. Keep out of reach of children.